GLP1R and cardiovascular disorder: The inclusion and analysis of all these parameters—GRACE and TIMI risk scores, in-hospital bleeding, medical therapy, Killip class, history of prior cardiovascular disease, and use of SGLT-2 inhibitors and GLP-1 receptor agonists—would likely have provided more comprehensive and meaningful prognostic insights.